Diagnosis and Management of Ocular Surface Disease - Mystery Versus Mastery | ASCRS
ASCRS SATELLITE CME Program

Diagnosis and Management of Ocular Surface Disease - Mystery Versus Mastery

Available On Demand Now

PARTICIPATE AND CLAIM CME AT YOUR CONVENIENCE

This program took place live on Wednesday, February 24, 2021 as is now available as an online CME activity through ASCRS CME 24/7.

Earn 1.0 AMA PRA Category 1 Credit™ by participating in this online CME activity.

Join our faculty as they clear up the mystery of diagnosing and managing ocular surface disease. This program explores how recognizing an early ocular surface disease diagnosis and treatment can impact your cataract and refractive surgical outcomes, dives into what diagnostic and therapeutic devices are available, and will provide the most up to date information on what treatment options are available. 

Begin Online CME Activity Now
ASCRS gratefully acknowledges the unrestricted educations grants received in support of this program from:

Johnson & Johnson
Novartis
 

ASCRS gratefully acknowledges the unrestricted educational grants received in support of the 2020 ASCRS Virtual Annual Meeting and Bonus CME Enduring Activities from:

Alcon Vision, LLC
Bausch + Lomb
Carl Zeiss Meditec
EyePoint Pharmaceuticals, Inc.
Omeros Corporation

Program Chairs

Marjan Farid, MD

Francis Mah, MD

Faculty

Brandon Ayres MD headshot

Brandon Ayres, MD

Preeya Gupta, MD

Christopher Starr, MD

Continuing Medical Education (CME) Credits

Accreditation Statement
The American Society of Cataract and Refractive Surgery is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ASCRS takes responsibility for the content, quality, and scientific integrity of the CME activity.

Designation Statement
The American Society of Cataract and Refractive Surgery designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Educational Objectives:

  • Evaluate patients for OSD using the latest diagnostic and therapeutic devices
  •  Compare and contrast OSD treatment options and indications
  • Recognize how early OSD diagnosis and treatment impacts cataract and refractive surgical outcomes

Claim CME/CE Credits

Attendees will be able to evaluate this webinar electronically. At the conclusion of the program, attendees will be emailed a link to the program evaluation and credit claim. Please contact Janell John, ASCRS CME Coordinator, at  jjohn@ascrs.org with any questions on credit claims.

Notice About Off-Label Use Presentations
The webinar may include presentations on drugs or devices or uses of drugs or devices that may not have been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. ASCRS is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASCRS of the uses, products or techniques presented.

ADA/Special Accommodations
ASCRS fully complies with the legal requirements of the American with Disabilities Act (ADA) and the rules and regulations thereof. ASCRS also requires ADA compliance from its contracted vendors and facilities. Any participant in this educational program who requires special accommodations or services should contact a staff member.

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.